£134.44

Modulators of Glutamatergic Signaling as Potential Treatments of Neuropsychiatric Disorders (Psychiatry - Theory, Applications and Treatments)

Psychiatry

Price data last checked 19 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£134 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 72 days · 72 data points (no recent data)

Historical

Generating forecast…

Price Distribution

Price distribution over 72 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £138 (71 days, 98.6%)

Price range: £134 - £138

Price levels: 2 different prices over 72 days

Description

Mounting evidence from preclinical and clinical research suggests that the glutamatergic system is highly involved in the pathophysiology of major neuropsychiatric disorders. All of these scientific activities are a necessary first step, which translates into opportunities in terms of development of new and improved treatment strategies. Glutamate-based research over the last couple of decades has provided novel insights into the pathogenesis of both psychiatric disorders such as treatment resistant depression, bipolar disorder, schizophrenia, PTSD, ADHD and neurological disorders including Alzheimer's dementia, migraine, epilepsy, ALS and neuropathic pain. Recent news developments also indicate glutamate involvement in neurodevelopmental disorders such as autism. In addition to the above, recent discoveries that several novel therapeutic agents like riluzole, memantine, ketamine, topiramate and lamotrigine possess glutamatergic properties as part of their mechanism of action, further boosted the interest of drug development companies and academic research centers to put more effort into investigating novel therapeutically efficacious compounds. Moreover, recent large "real life" clinical studies, such as STAR*D, also looked into disease-associated glutamate genetics and paved the way for the future creation of first individualised pharmacogenetic treatments. The overall purpose of this book is to provide the reader with expert opinions relating to the most up-to-date information on glutamate's role in pathophysiology of neuropsychiatric disorders and current and future glutamatergic treatment strategies. The authors' hope that this contribution will foster future research activities, which are all ultimately aiming to improve quality of life in patients with chronic, psychiatric and neurological disorders, thus enhancing their contribution to society.

Product Specifications

Format: hardcover
ASIN: 1634834933
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Other Branches of Medicine > Psychiatry
Domain: Amazon UK
Release Date: 01 December 2015
Listed Since: 14 July 2015

Barcode

No barcode data available

Modulators of Glutamatergic Signaling as Potential Treatments of Neuropsychiatric Disorders (Psychiatry - Theory, Applications and Treatments)

It has never been this cheap. We have no record of a lower price.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Metabotropic Glutamate Receptors in Psychiatric and Neurological Disorders: Volume 168 (International Review of Neurobiology, Volume 168)

Translational Neuropsychiatry: Integrating Neuroscience, Clinical Syndromes, and Therapeutic Strategies

Translational Neuropsychiatry: Integrating Neuroscience, Clinical Syndromes, and Therapeutic Strategies

Anatomy of Neuropsychiatry: The New Anatomy of the Basal Forebrain and Its Implications for Neuropsychiatric Illness

Natural Dualism and Mental Disorder: The Biocognitive Model for Psychiatry

Routledge Key Topics in Clinical Neuropsychology - BPS Series

Neuropsychological Effects of the Psychiatric Disorders (Psychology Revivals)

Modern Psychopharmacology: Integrating Neuroscience, Psychiatry & Ethics: , A Clinical and Scientific Framework for Understanding Brain, Behavior, and ... Interactions (The Language of Modern Science)

Understanding Cross-Cultural Neuropsychology: Science, Testing, and Challenges (Current Issues in Neuropsychology)

Horizons in Neuroscience Research: Volume 28

IntechOpen COVID-19 Pandemic, Mental Health and Neuroscience

Neuropsychology in the Age of Digital Health: Exploration, Application, and Practical Implementation

Non-pharmacological Interventions for Age-Related Neuropsychiatric Disorders: Volume 298 (Progress in Brain Research, Volume 298)

Neurociencia En Psiquiatría: Fisiopatología del Comportamiento Y Enfermedades Mentales

The Psychophysiology of Mental Illness (Psychology Revivals)

Contemporary Neuropsychiatry: Implications from Cognitive Neuroscience

Humanist Psychiatry (Psychiatry - Theory, Applications and Treatments)

Biomarkers of Neurological and Psychiatric Disease

Psychiatric Neurology: A Clinical Approach

Horizons in Neuroscience Research: Volume 25

Neuroticism: Characteristics, Impact on Job Performance & Health Outcomes (Psychology of Emotions, Motivations and Actions)

Medical and Laboratory Examinations for Neuropsychologists: A Clinical Guide

Neuroscience in the Age of Complexity (Neuroscience Research Progress)

Clinical Neuropsychology